Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Saxagliptin is a new oral hypoglycemic of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones and reducing fasting and postprandial glucose concentrations in a glucose-dependent manner in patients with type 2 diabetes mellitus.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 5 days | $ 970.00 |
Description | Saxagliptin is a new oral hypoglycemic of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones and reducing fasting and postprandial glucose concentrations in a glucose-dependent manner in patients with type 2 diabetes mellitus. |
Targets&IC50 | DPP4:0.6-1.3 nM (Ki) |
Synonyms | BMS477118, Saxagliptin, BMS 477118, Saxagliptin HCl, BMS-477118 |
Molecular Weight | 351.87 |
Formula | C18H26ClN3O2 |
CAS No. | 709031-78-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Saxagliptin hydrochloride 709031-78-7 Saxagliptin Hydrochloride BMS477118 Saxagliptin BMS 477118 Saxagliptin HCl BMS-477118 inhibitor inhibit